Rare, germline mutation of KIT with imatinib-resistant multiple GI stromal tumors and mastocytosis

J Clin Oncol. 2013 Jun 1;31(16):e245-7. doi: 10.1200/JCO.2012.42.0133. Epub 2013 Apr 22.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Agents / pharmacology*
  • Benzamides / pharmacology*
  • Biomarkers, Tumor / analysis
  • Drug Resistance, Neoplasm*
  • Exons
  • Gastrointestinal Neoplasms / complications
  • Gastrointestinal Neoplasms / diagnostic imaging
  • Gastrointestinal Neoplasms / drug therapy
  • Gastrointestinal Neoplasms / genetics*
  • Gastrointestinal Neoplasms / surgery
  • Gastrointestinal Stromal Tumors / complications
  • Gastrointestinal Stromal Tumors / diagnostic imaging
  • Gastrointestinal Stromal Tumors / drug therapy
  • Gastrointestinal Stromal Tumors / genetics*
  • Gastrointestinal Stromal Tumors / surgery
  • Germ-Line Mutation*
  • Humans
  • Imatinib Mesylate
  • Immunohistochemistry
  • Intestine, Small* / pathology
  • Intestine, Small* / surgery
  • Male
  • Mastocytosis / complications
  • Mastocytosis / genetics*
  • Piperazines / pharmacology*
  • Protein Kinase Inhibitors / pharmacology
  • Proto-Oncogene Proteins c-kit / analysis
  • Proto-Oncogene Proteins c-kit / genetics*
  • Pyrimidines / pharmacology*
  • Tomography, X-Ray Computed

Substances

  • Antineoplastic Agents
  • Benzamides
  • Biomarkers, Tumor
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Imatinib Mesylate
  • Proto-Oncogene Proteins c-kit